-
Feb 02, 2021 09:16 PM IST Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1070 in its research report dated January 19, 2021.
-
Jan 28, 2021 03:01 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 1055 in its research report dated January 20, 2021.
-
Oct 28, 2020 04:58 PM IST KR Choksey is bullish on Alembic Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1286 in its research report dated October 26, 2020.
-
Oct 25, 2020 12:05 PM IST ICICI Direct is bullish on Alembic Pharma recommended buy rating on the stock with a target price of Rs 1170 in its research report dated October 23, 2020.
-
Oct 23, 2020 03:35 PM IST YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated October 22, 2020.
-
Jul 24, 2020 04:41 PM IST ICICI Direct is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1140 in its research report dated July 23, 2020.
-
Jul 23, 2020 07:08 PM IST YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1180 in its research report dated July 22, 2020.
-
Jul 23, 2020 07:03 PM IST Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 1122 in its research report dated July 22, 2020.
-
Jul 07, 2020 01:41 PM IST Motilal Oswal recommended Neutral rating on Alembic Pharmaceuticals with a target price of Rs 975 in its research report dated July 05, 2020.
-
Jun 23, 2020 06:48 PM IST YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated June 15, 2020.
-
May 20, 2020 04:24 PM IST YES Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated May 19, 2020.
-
Apr 29, 2020 09:49 AM IST -
Jul 31, 2019 04:18 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 540 in its research report dated July 30, 2019.
-
May 09, 2019 04:56 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated May 09, 2019.
-
Jan 25, 2019 04:07 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 620 in its research report dated January 23, 2019.
-
Oct 24, 2018 03:59 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 560 in its research report dated October 23, 2018.
-
Jul 31, 2018 04:11 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 525 in its research report dated July 30, 2018.
-
May 24, 2018 05:52 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 460 in its research report dated May 17, 2018.
-
Nov 15, 2017 05:12 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 530 in its research report dated November 09, 2017.
-
Jul 25, 2017 05:35 PM IST KR Choksey recommended hold rating on Alembic Pharma with a target price of Rs 580 in its research report dated July 21, 2017.
-
Jul 25, 2017 03:32 PM IST ICICI Direct has recommended hold rating on Alembic Pharma with a target price of Rs 570 in its research report dated July 21, 2017.
-
Jul 24, 2017 01:31 PM IST HDFC Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated July 20, 2017.
-
May 10, 2017 04:24 PM IST Axis Direct recommended hold rating on Alembic Pharmaceuticals with a target price of Rs 610 in its research report dated May 09, 2017.
-
Jan 30, 2017 03:28 PM IST ICICI Direct recommended hold rating on Alembic Pharma with a target price of Rs 615 in its research report dated January 30, 2017.
-
Jan 30, 2017 01:31 PM IST KR Choksey has recommended accumulate rating on Alembic Pharma with a target price of Rs 667 in its research report dated January 27, 2017.